<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1699-714X</journal-id>
<journal-title><![CDATA[Revista de la OFIL ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. OFIL·ILAPHAR]]></abbrev-journal-title>
<issn>1699-714X</issn>
<publisher>
<publisher-name><![CDATA[Organización de Farmacéuticos Ibero-Latinoamericanos]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1699-714X2020000100012</article-id>
<article-id pub-id-type="doi">10.4321/s1699-714x20200001000012</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Retiro de medicamentos antineoplásicos en un hospital nacional en Costa Rica]]></article-title>
<article-title xml:lang="en"><![CDATA[Antineoplastic medication pick-up rates in a Costa Rica national hospital]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gurdián-Solórzano]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[León-Salas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cartín-Ruiz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santamaría-Ulloa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital del Trauma  ]]></institution>
<addr-line><![CDATA[San José ]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Costa Rica Facultad de Farmacia Departamento de Atención Farmacéutica y Farmacia Clínica]]></institution>
<addr-line><![CDATA[San José ]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital México Servicio de Farmacia ]]></institution>
<addr-line><![CDATA[San José ]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de Costa Rica Instituto de Investigaciones en Salud ]]></institution>
<addr-line><![CDATA[San José ]]></addr-line>
<country>Costa Rica</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<volume>30</volume>
<numero>1</numero>
<fpage>47</fpage>
<lpage>51</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1699-714X2020000100012&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1699-714X2020000100012&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1699-714X2020000100012&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objectivo: Analizar los porcentajes de dosis retiradas de medicamentos oncológicos no incluidos en la Lista Oficial de Medicamentos según el servicio médico prescriptor y la vía de administración del fármaco, en un hospital de tercer nivel de atención en Costa Rica.  Métodología: Los datos fueron obtenidos de manera retrospectiva a partir de bases de datos desarrolladas a nivel hospitalario para el control de los medicamentos adquiridos y a partir de los registros de medicamentos despachados.  Resultados: Las unidades aprobadas para compra en los Servicios de Oncología y Hematología no son retiradas en su totalidad por los pacientes en tratamiento oncológico. En general, el porcentaje de retiro fue de 90,3% para 98 solicitudes de compra. Existen diferencias estadísticamente significativas en los porcentajes de retiro según el servicio médico prescriptor (t=-2,68; p=0,01) y la vía de administración de los medicamentos (t=-2,61; p=0,01). Del análisis multivariado se desprende que en el Servicio de Oncología Médica el porcentaje de retiro de medicamentos es significativamente menor entre las personas divorciadas (ß=-4,7; p&lt;0,01) y viudas (ß=-20,5; p=0,01) en comparación con las personas casadas.  Conclusiones: El retiro de medicamentos, si bien no es una forma de medir la adherencia terapéutica, permite establecer una relación primaria entre el paciente y el tratamiento a administrar. El sub-retiro de medicamentos encontrado mediante este estudio evidencia la necesidad de ampliar la investigación con el fin de conocer los motivos por los que los pacientes no retiran sus tratamientos oncológicos de compra.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY  Objective: To analyze the percentage of picked-up doses of oncologic drugs not included in the Essential Medicine List according to the medical prescribing service and the administration route of the drug in a third level hospital in Costa Rica.  Method: Data was obtained by retrospective analysis from databases developed for the hospital's control of acquired drugs and from the dispatched drug registry.  Results: Not all medications acquired through the special drug buying mechanism are picked-up by patients from the Oncology and Hematology Services. Overall, the pick-up rate was 90.3% for the 98 processes analyzed. Significant differences for the picking-up percentages were found for the medical prescribing service (t=-2.68; p=0.01) and the drug´s administration route (t=-2.61; p=0.01). Multivariate analysis shows that for the Medical Oncology Service, pick-up rate is significantly lower among divorced (ß=-4.7; p&lt;0.01) and widowed (ß=-20.5; p=0.01) patients compared to married ones.  Conclusions: Even when pick-up rates are not a way to measure therapeutic adherence, they allow to establish a primary relationship between the patient and its treatment. The underpicking of treatments found by this study shows the need to increase the research in order to understand patient´s reasons to abandon oncologic treatments that are not included in the Essential Medicine List.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Antineoplásicos]]></kwd>
<kwd lng="es"><![CDATA[cumplimiento]]></kwd>
<kwd lng="es"><![CDATA[retiro]]></kwd>
<kwd lng="es"><![CDATA[Oncología Médica]]></kwd>
<kwd lng="es"><![CDATA[Hematología]]></kwd>
<kwd lng="en"><![CDATA[Antineoplastic]]></kwd>
<kwd lng="en"><![CDATA[patient compliance]]></kwd>
<kwd lng="en"><![CDATA[pick-up rates]]></kwd>
<kwd lng="en"><![CDATA[Medical Oncology]]></kwd>
<kwd lng="en"><![CDATA[Hematology]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[WHO Cancer]]></source>
<year></year>
<publisher-loc><![CDATA[Génova ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz-Amaya]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Reyes]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Trujillo-Osorio]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Palacios-Espinosa]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cumplimiento con la quimioterapia intravenosa y algunos factores asociados a éste en pacientes oncológicos adultos]]></article-title>
<source><![CDATA[Avances en Psicología Latinoamericana]]></source>
<year>2013</year>
<volume>31</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>467-82</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Olivera-Fernandez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandez-Ribeiro]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Piñeiro-Corrales]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Crespo-Diz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia a tratamientos antineoplásicos orales]]></article-title>
<source><![CDATA[Farmacia Hospitalaria]]></source>
<year>2014</year>
<volume>38</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>475-81</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palacios-Espinosa]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas-Sterling]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia a la quimioterapia y radioterapia en pacientes oncológicos: una revisión de la literatura]]></article-title>
<source><![CDATA[Psicooncología]]></source>
<year>2012</year>
<volume>8</volume>
<numero>2-3</numero>
<issue>2-3</issue>
<page-range>423-40</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bender]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Gentry]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Brufsky]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Casillo]]></surname>
<given-names><![CDATA[FE]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Dailey]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influence of Patient and Treatment Factors on Adherence to Adjuvant Endocrine Therapy in Breast Cancer]]></article-title>
<source><![CDATA[Oncology Nursing Forum]]></source>
<year>2014</year>
<volume>41</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>274-85</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mislang]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Wildes]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Kanesvaran]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Baldini]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Holmes]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Nightingale]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendations]]></article-title>
<source><![CDATA[Cancer Treatment Reviews]]></source>
<year>2017</year>
<volume>57</volume>
<page-range>58-66</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Timmers]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Swart]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Boons]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mangnus]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[van de Ven]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Peters]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The use of capecitabine in daily practice: a study on adherence and patients' experiences]]></article-title>
<source><![CDATA[Patient Preference and Adherence]]></source>
<year>2012</year>
<volume>741</volume>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hall]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Paul]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bryant]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lynagh]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Rowlings]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Enjeti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[To adhere or not to adhere: Rates and reasons of medication adherence in hematological cancer patients]]></article-title>
<source><![CDATA[Critical Reviews in Oncology/Hematology]]></source>
<year>2016</year>
<volume>97</volume>
<page-range>247-62</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thivat]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Van Praagh]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Belliere]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mouret-Reynier]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Kwiatkowski]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Durando]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherence with Oral Oncologic Treatment in Cancer Patients: Interest of an Adherence Score of All Dosing Errors]]></article-title>
<source><![CDATA[Oncology]]></source>
<year>2013</year>
<volume>84</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>67-74</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Greer]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Amoyal]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Nisotel]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Fishbein]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
<name>
<surname><![CDATA[MacDonald]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Stagl]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Systematic Review of Adherence to Oral Antineoplastic Therapies]]></article-title>
<source><![CDATA[The Oncologist]]></source>
<year>2016</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>354-76</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pop]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Postolica]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lup&#259;u]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Dégi]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical Practice Guide in Psycho-oncology]]></article-title>
<source><![CDATA[Cognitie, Creier, Comportament/Cognition, Brain, Behavior]]></source>
<year>2016</year>
<volume>20</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kajioka]]></surname>
<given-names><![CDATA[EH]]></given-names>
</name>
<name>
<surname><![CDATA[Itoman]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Taira]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[GG]]></given-names>
</name>
<name>
<surname><![CDATA[Yamamoto]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pediatric prescription pick-up rates after ED visits]]></article-title>
<source><![CDATA[The American Journal of Emergency Medicine]]></source>
<year>2005</year>
<volume>23</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>454-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shafrin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sullivan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chou]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Neely]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Doan]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Maclean]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma]]></article-title>
<source><![CDATA[Cancer Management and Research]]></source>
<year>2017</year>
<page-range>9731-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santoleri]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Sorice]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lasala]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rizzo]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Costantini]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patient Adherence and Persistence with Imatinib, Nilotinib, Dasatinib in Clinical Practice]]></article-title>
<source><![CDATA[PLoS ONE]]></source>
<year>2013</year>
<volume>8</volume>
<numero>2</numero>
<issue>2</issue>
<publisher-name><![CDATA[Eaves CJ]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[WHO Essential medicines]]></source>
<year></year>
<publisher-loc><![CDATA[Génova ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="">
<collab>World Health Organization</collab>
<article-title xml:lang=""><![CDATA[WHO Model List of Essential Medicines: 20th list]]></article-title>
<source><![CDATA[]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="book">
<collab>Caja Costarricense de Seguro Social, Dirección de Farmacoepidemiología</collab>
<source><![CDATA[NORMATIVA LOM 2016. Caja Costarricense de Seguro Social]]></source>
<year>2016</year>
<publisher-name><![CDATA[Dirección de Farmacoepidemiología]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="">
<collab>Instituto Nacional de Estadística y Censos - Ministerios de Salud, Vigilancia de la Salud, Unidad de Seguimiento de Indicadores de Salud</collab>
<source><![CDATA[Mortalidad por los Diez Tumores más Frecuentes en Hombres por Grupos de Edad 2015]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="">
<collab>Instituto Nacional de Estadística y Censos - Ministerios de Salud, Vigilancia de la Salud, Unidad de Seguimiento de Indicadores de Salud</collab>
<source><![CDATA[Mortalidad por los Diez Tumores más Frecuentes en Mujeres por Grupos de Edad 2015]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Adherencia a los tratamientos a largo plazo. Pruebas para la acción]]></source>
<year>2004</year>
<edition>1</edition>
<publisher-loc><![CDATA[Washington, D.C. ]]></publisher-loc>
<publisher-name><![CDATA[Organización Mundial de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="">
<collab>Cancer Research UK</collab>
<source><![CDATA[Cancer survival for common cancers]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[UH]]></given-names>
</name>
<name>
<surname><![CDATA[Dueñas]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[KY]]></given-names>
</name>
<name>
<surname><![CDATA[Polo]]></surname>
<given-names><![CDATA[YP]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Perdomo-Romero]]></surname>
<given-names><![CDATA[AY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia al tratamiento de quimioterapia y radioterapia en pacientes con cáncer gástrico y colorrectal en las unidades oncológicas]]></article-title>
<source><![CDATA[RFS Revista Facultad de Salud]]></source>
<year>2014</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>14-9</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="book">
<collab>Organización Panamericana de la Salud. Costa Rica</collab>
<source><![CDATA[Salud en las Américas Panorama regional y perfiles de país]]></source>
<year>2012</year>
<page-range>96-9</page-range><publisher-loc><![CDATA[Washington, D.C. ]]></publisher-loc>
<publisher-name><![CDATA[OPS]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
